Skip Navigation


Journal of the National Cancer Institute Advance Access originally published online on September 11, 2007
JNCI Journal of the National Cancer Institute 2007 99(18):1415-1416; doi:10.1093/jnci/djm108
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
99/18/1415    most recent
djm108v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Johnston, K. L.
Right arrow Articles by Go, R. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Johnston, K. L.
Right arrow Articles by Go, R. S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press.

CORRESPONDENCE

Financial Conflicts of Interest Among ASCO Annual Meeting Abstract Authors, Speakers, and Planners

Kaye L. Johnston, Ronald S. Go

Affiliation of authors: Center for Cancer and Blood Disorders, Gundersen Lutheran Health System, La Crosse, WI

Correspondence to: Ronald S. Go, MD, Center for Cancer and Blood Disorders, Gundersen Lutheran Health System, Mail Stop: EB02-001, 1900 South Ave, La Crosse, WI 54601 (e-mail: rsgo@gundluth.org).

The first 10% of the full text of this article appears below.

Financial relationships between academic medical centers and industry are common, and there is a current debate as to how to regulate financial conflicts of interest (FCOIs) (1). Advocates of stricter regulation argue that disclosure alone does not minimize conflicts (2), but others maintain that reported misbehaviors are few and that stricter regulation would stifle medical progress and collaborations between academia and industry (3).

Among all diseases, . . . [Full Text of this Article]

Funding


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?